ACS Chemical Biology · 2020 · 13 citations · 39 references
MedicineMolecular BiologyPharmacologyBiosensorsDrug DiscoveryMolecular OncologyLigand BindingProtein TargetingTargeted Cancer TherapyDruggable Target DiscoveryFörster Resonance Energy Transfer (Fret)Förster Resonance Energy Transfer SensorsHigh-throughput Screening AssaysMacromolecular Complex FormationMolecular Drug ResistanceProtein Binding In OncologyTumor Aggressiveness Assessment
values in the low micromolar range. Interestingly, two of these compounds bind to YB1 and sensitize drug-resistant breast tumor cells to the chemotherapeutic agent, cisplatin. Taken together, these findings demonstrate that the hNTH1-YB1 interface is a druggable target for the development of new therapeutic strategies for the treatment of drug-resistant tumors. Moreover, beyond this study, the simple design of our biosensor defines an innovative and efficient strategy for the screening of inhibitors of therapeutically relevant protein-protein interfaces.
39
Base Excision Repair of Oxidative DNA Damage Activated by XPG Protein
Arne Klungland, Matthias Höss, Daniela Gunz et al. · Molecular Cell · 1999 · 287 citations · Full text